EFFECTS OF TIBOLONE ON BLOOD CALCIUM AND VITAMIN D3 LEVELS AFTER MENOPAUSE.
Not Applicable
- Conditions
- Health Condition 1: null- POST MENOPAUSAL WOMEN- (SURGICALLY AND NATURALLY) WITH MENOPAUSAL SYMPTOMS.
- Registration Number
- CTRI/2012/06/002752
- Lead Sponsor
- SCDAS MEMORIAL MEDICAL AND RESEARCH CENTER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
MENOPAUSAL WOMEN WITH DISTRESSING MENOPAUSAL SYMPTOMS NEEDING HORMONE REPLACEMENT THERAPY WILL BE TREATED WITH TIBOLONE 2.5 MG DAILY TABLETS. AT BASELINE SERUM CALCIUM AND 25-HYDROXY VITAMIN D3 LEVELS WILL BE MEASURED AND AGAIN THE TESTS WILL BE REPEATED AFTER 6 MONTHS WHILE ON TIBOLONE TREATMENT.
Exclusion Criteria
CASES WITH HISTORY OF INTAKE OF OTHER FORMS OF HORMONE REPLACEMENT THERAPIES IN THE PRECEDING 3 MONTHS;CASES ALREADY ON CALCIUM AND VITAMIN D3 SUPPLEMENTATION;CASES WITH UNCONTROLLED HYPERTENSION AND DIABETES; CASES WITH HYPERSENSITIVITY TO TIBOLONE.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method